Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends

ARDS
Aridis Pharmaceuticals Inc
stock NASDAQ

At Close
3/24/2023 3:59:30 PM EDT
0.3951USD-3.634%(-0.0149)268,969
0.3161Bid   0.4320Ask   0.1159Spread IEX
Pre-market
3/24/2023 9:20:30 AM EDT
0.4100USD0.000%(0.0000)0
After-hours
3/23/2023 4:03:30 PM EDT
0.4290USD+7.250%(+0.0290)0
OverviewOption ChainHistoricalExchange VolumeShort VolumeBorrow FeeFailure to DeliverTrendsNewsNews
Jan 27, 2022
09:57AM EST  HC Wainwright Reiterates Buy And $19 Price Target On Aridis Pharmaceuticals   Benzinga
09:07AM EST  Benzinga Pro's Top 5 Stocks To Watch For Thursday, Jan. 27, 2022: XLNX, ARDS, LRCX, HOOD, WDC   Benzinga
07:58AM EST  The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study   Benzinga
07:15AM EST  Aridis Gets $1.9 Mln Funding From Gates Foundation To   RTTNews
06:47AM EST  Aridis Pharmaceuticals Announced Funding to Evaluate Inhaled Monoclonal Antibodies to Block Influenza and SARS-CoV-2 Transmission   Benzinga
06:47AM EST  Aridis Pharma Receives Funding To Evaluate Inhaled Monoclonal Antibodies To Block Influenza And SARS-CoV-2 Transmission   RTTNews
06:45AM EST  Aridis Pharmaceuticals Receives Funding to Evaluate Inhaled Monoclonal   PR Newswire
05:01AM EST  41 Biggest Movers From Yesterday   Benzinga
Jan 20, 2022
10:08AM EST  Aridis Pharmaceuticals Tweets 'We are rescheduling our group call, as we have some very exciting #news coming. Stay tuned!'   Benzinga
Jan 19, 2022
04:41PM EST  Aridis Pharma Filing Shows Registration For $25M Common Stock Shelf Offering   Benzinga
Dec 21, 2021
02:56PM EST  Aridis Pharma Press Release Highlights Comments By Co. CEO During Fox Business Interview   Benzinga
02:55PM EST  Aridis Pharmaceuticals CEO Discusses Monoclonal Antibody Cocktail Protection   PR Newswire
02:47PM EST  Mid-Afternoon Market Update: Dow Jumps Over 500 Points; Rite Aid Shares Spike Higher   Benzinga
12:33PM EST  Mid-Day Market Update: Crude Oil Rises 3%; Aldeyra Therapeutics Shares Slide   Benzinga
11:43AM EST  Watching Aridis Pharmaceuticals; Maxim Reiterates $13 Price Target, Buy Rating   Benzinga
11:43AM EST  Aridis Pharmaceuticals Shares Up 39%; Cantor Reiterates Overweight Rating, $18 Price Target   Benzinga
11:39AM EST  Watching Aridis Pharmaceuticals; Hearing Maxim Reiterates $13 Price Target, Buy Rating   Benzinga
11:39AM EST  Aridis Pharmaceuticals Shares Up 39%; Hearing Cantor Reiterates Overweight Rating, $18 Price Target   Benzinga
08:12AM EST  The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail   Benzinga
04:44AM EST  Aridis Pharmaceuticals Announced Pan-Coronavirus Monoclonal Antibody Cocktail That Retains Effectiveness Against the Omicron variant, other COVID-19 Variants, SARS, MERS, and the Common Cold Human Coronaviruses   Benzinga
04:26AM EST  Aridis Pharma Says Pan-Coronavirus Monoclonal Antibody Cocktail That Retains Effectiveness Against Omicron, COVID-19   RTTNews
04:12AM EST  That Retains Effectiveness Against the Omicron variant, other COVID-19 Variants, SARS, MERS, and the Common Cold Human Coronaviruses   PR Newswire
Nov 10, 2021
08:19AM EST  Aridis Pharmaceuticals Q3 EPS $(1.94) Down From $(0.65) YoY   Benzinga
08:05AM EST  Aridis Pharmaceuticals Announces Third Quarter 2021 Results   PR Newswire
Oct 6, 2021
07:33AM EDT  The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal   Benzinga
Oct 1, 2021
07:56AM EDT  The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO   Benzinga
Sep 28, 2021
08:18AM EDT  The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive   Benzinga
08:16AM EDT  The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK To Develop Long-Acting HIV Treatments   Benzinga
Aug 20, 2021
07:45AM EDT  The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data   Benzinga
Aug 17, 2021
08:28AM EDT  The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business   Benzinga
Aug 13, 2021
04:26PM EDT  Aridis Pharmaceuticals Files Shelf Related To Offering of 884,956 Shares Of Common Stock By Selling Stockholder   Benzinga
07:43AM EDT  The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO   Benzinga
Aug 12, 2021
09:14AM EDT  Aridis Pharmaceuticals Q2 EPS $(0.49) Down From $(0.47) YoY, Sales $33.00K Down From $1.00M YoY   Benzinga
09:06AM EDT  Aridis Pharma Q2 Net Loss $5.5 Mln Or $0.49/shr Vs. Net Loss $4.2 Mln Or $0.47/shr Prior Year   RTTNews
09:04AM EDT  Aridis Pharmaceuticals Announces Second Quarter 2021 Results   PR Newswire
Aug 6, 2021
07:42AM EDT  The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO   Benzinga
Aug 5, 2021
08:08AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO   Benzinga
Aug 4, 2021
07:52AM EDT  The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings   Benzinga
Aug 2, 2021
08:10AM EDT  Aridis Pharma Announces $25 Mln Registered Direct Offering Priced At A Premium To Market   RTTNews
08:07AM EDT  Aridis Pharmaceuticals Announces $25M Registered Direct Offering Priced At A Premium To Market; 4.947M Shares At $5.053/Share   Benzinga
08:02AM EDT  Aridis Pharmaceuticals Announces $25 Million Registered Direct Offering Priced   PR Newswire
Jul 28, 2021
07:33AM EDT  The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal   Benzinga
Jul 26, 2021
08:31AM EDT  Aridis Pharmaceuticals' COVID mAb Ranks Among the Top 5 Most Potent COVID-19   PR Newswire
Jul 20, 2021
06:09AM EDT  HC Wainwright & Co. Maintains Buy on Aridis Pharmaceuticals, Raises Price Target to $19   Benzinga
Jul 19, 2021
09:55AM EDT  Aridis In-Licenses Pneumonia Candidate From AstraZeneca   Benzinga
08:53AM EDT  Aridis Pharmaceuticals Inc. (ARDS) said that it has acquired global exclusive rights from AstraZeneca (AZN, AZN.L) for development and commercialization of the late stage monoclonal antibody candidate suvratoxumab for all indications.   RTTNews
08:33AM EDT  Aridis Pharmaceuticals Announces Exclusive License Of Suvratoxumab Phase 3-Ready Monoclonal Antibody From AstraZeneca; Highlights Uo To $30M Funding From EU Commission For Phase 3 Trial   Benzinga
08:32AM EDT  Aridis Announces License Of Suvratoxumab, Phase 3-Ready Monoclonal Antibody, From AstraZeneca   RTTNews
08:31AM EDT  Aridis Pharmaceuticals Announces Exclusive License of Suvratoxumab, a Phase   PR Newswire
Jul 13, 2021
02:38PM EDT  Mid-Afternoon Market Update: Dow Falls 75 Points; Red Cat Holdings Shares Spike Higher   Benzinga
12:05PM EDT  Mid-Day Market Update: Howard Bancorp Jumps Following Merger News; Gatos Silver Shares Slide   Benzinga
08:05AM EDT  The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data   Benzinga
06:41AM EDT  Aridis Pharma's COVID-19 Antibody Neutralizes Delta Variant In Animal Model   Benzinga
Jul 12, 2021
06:04PM EDT  Biopharmaceutical company Aridis Pharmaceuticals Inc. (ARDS) Monday said its COVID-19 mAb cocktail AR-712 binds and neutralizes the Delta variant virus SARS-CoV-2 at a highly effective level. Shares gain over 5% in after-hours trading, following the news.   RTTNews
04:07PM EDT  Aridis Pharmaceuticals COVID mAb AR-712 Neutralizes SARS-CoV-2 Delta Variant   PR Newswire
04:06PM EDT  Aridis Pharmaceuticals Says Texas Biomedical Research Institute Data Confirm's Co.'s AR-712 Neutralizes SARS-CoV-2 Delta Variant   Benzinga
May 24, 2021
04:24PM EDT  Aridis Pharma 8-K Shows Co. CFO, Michael Nazak, Resigned; Names Fred Kurland Interim Principal Financial, Accounting Officer   Benzinga
May 11, 2021
04:13PM EDT  Aridis Pharmaceuticals Q1 EPS $(0.77) Down From $(0.73) YoY   Benzinga
04:01PM EDT  Aridis Pharmaceuticals Announces First Quarter 2021 Results   PR Newswire
Apr 1, 2021
12:29PM EDT  Aridis Pharmaceuticals Granted Patent From European Patent Office Doc Titled 'HUMAN MONOCLONAL ANTIBODY SPECIFIC FOR THE F PROTEIN OF RESPIRATORY SYNCYTIAL VIRUS (RSV)'   Benzinga
Mar 30, 2021
05:50PM EDT  Aridis Pharmaceuticals Announces 2020 Fourth Quarter and Year-End Financial   PR Newswire
Mar 26, 2021
08:01AM EDT  Aridis Pharmaceuticals Interview to Air on Bloomberg Television U.S. on the   PR Newswire
Mar 8, 2021
08:50AM EST  Aridis, Kermode Enter In Licensing And Discovery Agreement For Zoonotic Viruses   Benzinga
08:45AM EST  Aridis Enters into APEX(tm) Licensing and Product Discovery Agreement for   PR Newswire
07:37AM EST  Aridis Announces Out-Licensing Agreement And Product Discovery Agreement With Kermode Biotechnologies; Specific Financial Terms Not Disclosed   Benzinga
Feb 23, 2021
07:25AM EST  The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts   Benzinga
07:21AM EST  Aridis Pharma To Test Inhaled Antibody Cocktail In COVID-19 Variants   Benzinga
05:52AM EST  Aridis Pharma Augments Inhaled AR-711 MAb To COVID-19 With A Second MAb AR-713 To Neutralize COVID-19 Mutated Variants   RTTNews
05:30AM EST  of a Second Inhaled Antibody to Neutralize Newly Emerging COVID-19 Mutated Variants   PR Newswire
Nov 24, 2020
05:30AM EST  Outlook for its Lead Programs and Novel mAb Discovery Platform on December 4th, 2020   PR Newswire
Nov 20, 2020
04:22PM EST  Aridis Pharmaceuticals Q3 Loss/share $0.65 Vs. Loss $0.87 Year Ago   RTTNews
04:07PM EST  Aridis Pharmaceuticals Q3 EPS $(0.65) Up From $(0.87) YoY   Benzinga
04:06PM EST  Aridis Pharmaceuticals Announces Third Quarter 2020 Results   PR Newswire
Oct 27, 2020
04:25PM EDT  /C O R R E C T I O N -- Aridis Pharmaceuticals, Inc./   PR Newswire
05:30AM EDT  Aridis Pharmaceuticals to Present at the ROTH Capital Partners 2020 MedTech   PR Newswire
Oct 19, 2020
08:33AM EDT  Aridis Pharmaceuticals Announces Development Of AR-711 Neutralizing Monoclonal Antibody   Benzinga
08:31AM EDT  Effective Inhaled Treatment Supporting a Proposed Self-Administered Therapy for COVID-19 Patients   PR Newswire
Oct 15, 2020
06:32AM EDT  Aridis Pharmaceuticals Files Prospectus Supplement Related To Offering Of 1.1M Shares Of Common Stock   Benzinga
Oct 14, 2020
05:39AM EDT  Aridis Pharmaceuticals Announced 1.13M Share Registered Direct Offering Priced @ $7.4925/Share   Benzinga
05:34AM EDT  Aridis Pharmaceuticals Plans $8.5 Mln Registered Direct Offering   RTTNews
05:30AM EDT  Aridis Pharmaceuticals Announces $8.5 Million Registered Direct Offering   PR Newswire
Sep 8, 2020
05:40AM EDT  Aridis Reaches Agreement With FDA To Simplify AR-501 Phase 2 Trial Design   RTTNews
05:32AM EDT  Aridis Reaches Agreement with the FDA on Simplified Phase 2 Clinical Trial Design for AR-501   Benzinga
05:30AM EDT  Aridis Announces Agreement with the FDA on Updated Phase 2 Clinical Trial   PR Newswire
Sep 4, 2020
01:33PM EDT  Aridis Pharmaceuticals to Present at Upcoming Investor Conferences   PR Newswire
Aug 11, 2020
04:30PM EDT  Aridis Pharmaceuticals Q2 EPS $(0.47) Up From $(1.03) YoY, Sales $1.00K   Benzinga
04:06PM EDT  Aridis Pharmaceuticals Announces Second Quarter 2020 Results   PR Newswire


Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter
ChartExchange on Reddit
© 2020 - 2023 ChartExchange LLC